Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07126886 · ClinicalTrials.gov registry record · Phase 4
A Multicenter, Prospective, Clinical Trial Evaluating a Single Layer Amniotic Membrane and Standard of Care Versus Matched Controls in the Management of Nonhealing Pressure Ulcers
A Phase 4 study of Pressure Ulcer and Ulcer, Pressure, sponsored by Applied Biologics.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT07126886: Recruiting Phase 4 study of Pressure Ulcer and Ulcer, Pressure, sponsored by Applied Biologics.
NCT07126886 is a Phase 4 study of Pressure Ulcer and Ulcer, Pressure that is actively recruiting participants, run by Applied Biologics. The registered enrollment target is 100 participants, below the 30,107-participant average among 10 other Pressure Ulcer trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07126886, a Phase 4 study of Pressure Ulcer and Ulcer, Pressure, is actively recruiting participants, sponsored by Applied Biologics.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
A multicenter, prospective, clinical trial evaluating a single-layer amniotic membrane (XPURT) and standard of care versus matched controls in the management of nonhealing pressure ulcers.
Primary Outcome
The percentage of target ulcers achieving complete wound closure in 20 weeks.
Conditions Studied
Interventions
- OTHER Standard of Care
- OTHER XPURT + SOC
Study Locations (1)
Pennsylvania
- Serena Group- Monroeville - Monroeville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-06-11 |
| Est. Completion | 2027-08 |
| Phase | Phase 4 |
What NCT07126886 shows while recruiting
NCT07126886 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 30,107-participant average among 10 other Pressure Ulcer trials with a reported enrollment target (100% lower).
The record links to 4 conditions, with Pressure Ulcer appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.
NCT07126886 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07126886 about?
NCT07126886 is a clinical study titled "A Multicenter, Prospective, Clinical Trial Evaluating a Single Layer Amniotic Membrane and Standard of Care Versus Matched Controls in the Management of Nonhealing Pressure Ulcers". A multicenter, prospective, clinical trial evaluating a single-layer amniotic membrane (XPURT) and standard of care versus matched controls in the management of nonhealing pressure ulcers.
What is the current status of trial NCT07126886?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2025-06-11. Estimated completion is 2027-08.
What conditions does trial NCT07126886 study?
This clinical trial studies the following conditions: Pressure Ulcer, Ulcer, Pressure, Pressure Wound, Pressure Area.
What interventions are being tested in trial NCT07126886?
The interventions under investigation include: Standard of Care (OTHER), XPURT + SOC (OTHER).
Who is sponsoring clinical trial NCT07126886?
This trial is sponsored by Applied Biologics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07126886 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pressure Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07126886's enrollment target sits among peer trials
100 4th of 10 higher than 6 of 10 other Pressure Ulcer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pressure Ulcer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Matched Standard of Care Controls in the Management of Nonhealing Pressure Ulcers
RECRUITING · Phase 4
-
A Real-World Registry of Chronic Wounds and Ulcers
RECRUITING
-
Evaluating Clinical Acceptance of a NPWT Wound Care System
COMPLETED · NA
-
The RESPOND Registry
COMPLETED
-
Evaluating Blast-X® in Combination With Negative Pressure Wound Therapy
COMPLETED · NA
-
AFT/CLP-LAL RCT Stage 3 or 4 Pressure Injuries
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI